3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Neoplasms
8
Colorectal Neoplasms
7
Prostatic Neoplasms
6
Stomach Neoplasms
5
Lung Neoplasms
5
Breast Neoplasms
5
Pancreatic Neoplasms
4
Endometrial Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sarcoma
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Oropharyngeal Neoplasms
2
Obesity
2
Meningioma
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Surgical Wound Dehiscence
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Small Cell Lung Carcinoma
1
Skull Base Neoplasms
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Interventions
Bevacizumab
40
Paclitaxel
35
Carboplatin
28
pembrolizumab
21
Cyclophosphamide
15
Specimen Handling
14
Cisplatin
13
olaparib
11
Blood Specimen Collection
11
niraparib
10
fludarabine
10
Magnetic Resonance Spectroscopy
9
Drug Therapy
9
liposomal doxorubicin
8
Topotecan
8
Taxes
8
Gemcitabine
8
Biopsy
8
Fulvestrant
7
Doxorubicin
6
cemiplimab
5
abemaciclib
5
Surveys and Questionnaires
5
Standard of Care
5
Injections
5
Fluorouracil
5
Cytoreduction Surgical Procedures
5
trastuzumab deruxtecan
4
mirvetuximab soravtansine
4
aldesleukin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Ovarian Neoplasms
×
Observation
×
Clear all
NCT02073500
2021-07-28
PSM
Oslo University Hospital
Recruiting
300 enrolled